Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle Cramp Rate, Severity and Burden in Maintenance Hemodialysis Patients: A Yearlong Multicenter Quality Improvement Initiative.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Medication Burden and Regimen Complexity Among Dialysis Patients from 2003 to 2024.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Dialysis Facility Closures: Fraying a Fragile Lifeline for People With Kidney Failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM).

Kidney360·2026
Same author

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Kidney360·2026

Related Experiment Video

Updated: Jun 20, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

Computerized decision support for EPO dosing in hemodialysis patients.

Dana C Miskulin1, Daniel E Weiner, Hocine Tighiouart

  • 1Tufts Medical Center, Boston, MA 02111, USA. dmiskulin@tuftsmedicalcenter.org

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|September 29, 2009
PubMed
Summary

Computerized decision support for erythropoietin (EPO) dosing in hemodialysis patients did not improve hemoglobin levels but significantly reduced staff time. This anemia management approach offers efficiency gains for dialysis units.

Related Experiment Videos

Last Updated: Jun 20, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

Area of Science:

  • Nephrology
  • Hematology
  • Health Informatics

Background:

  • Anemia management in hemodialysis patients presents significant clinical challenges.
  • Intravenous erythropoietin (EPO) is a cornerstone therapy for anemia in this population.
  • Optimizing EPO dosing and monitoring is crucial for patient outcomes and resource utilization.

Purpose of the Study:

  • To evaluate the impact of computerized decision support (CDS) for EPO dosing on hemoglobin (Hb) levels in hemodialysis patients.
  • To assess the effect of CDS on staff time dedicated to anemia management.
  • To compare CDS with traditional manual physician-directed EPO dosing.

Main Methods:

  • A retrospective cohort study comparing patients receiving EPO via CDS versus manual dosing.
  • Included in-center hemodialysis patients treated between October 2005 and April 2006.
  • Analyzed monthly Hb values, EPO quantities, and staff time across 18 units (CDS) and 125 units (manual dosing), involving 1,118 and 7,823 patients, respectively.

Main Results:

  • No significant difference was observed in achieving target monthly Hb levels (10-12 g/dL) between CDS and manual dosing groups.
  • CDS was associated with a decrease in Hb levels >12 g/dL and an increase in Hb levels <10 g/dL.
  • A statistically significant, nearly 50% reduction in staff time spent on anemia management was noted with CDS (P < 0.001).
  • EPO utilization was 4% lower with CDS, though not statistically significant.

Conclusions:

  • Computerized decision support for EPO dosing in hemodialysis does not appear to improve glycemic control within target ranges compared to manual dosing.
  • EPO use was not significantly different between the two methods.
  • CDS significantly reduces the workload for dialysis unit staff involved in anemia management, offering substantial operational efficiencies.